ACTICLATE CAP Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Acticlate Cap, and when can generic versions of Acticlate Cap launch?
Acticlate Cap is a drug marketed by Chartwell Rx and is included in one NDA.
The generic ingredient in ACTICLATE CAP is doxycycline hyclate. There are twenty-eight drug master file entries for this compound. Seventy-four suppliers are listed for this compound. Additional details are available on the doxycycline hyclate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Acticlate Cap
A generic version of ACTICLATE CAP was approved as doxycycline hyclate by CARIBE HOLDINGS on November 8th, 1982.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ACTICLATE CAP?
- What are the global sales for ACTICLATE CAP?
- What is Average Wholesale Price for ACTICLATE CAP?
Summary for ACTICLATE CAP
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 55 |
| Patent Applications: | 438 |
| DailyMed Link: | ACTICLATE CAP at DailyMed |
Pharmacology for ACTICLATE CAP
| Drug Class | Tetracycline-class Drug |
US Patents and Regulatory Information for ACTICLATE CAP
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chartwell Rx | ACTICLATE CAP | doxycycline hyclate | CAPSULE;ORAL | 208253-001 | Apr 26, 2016 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
